Selection of RNAi-based inhibitors for anti-HIV gene therapy

doi:10.5501/wjv.v1.i3.79

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 3

This Article

(0)

(6982)

(16)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Guidelines for Basic Science

World J Virol. Jun 12, 2012; 1(3): 79-90
Published online Jun 12, 2012. doi: 10.5501/wjv.v1.i3.79

Full Size Figure Download Figure

Figure 1 Selection of short hairpin RNAs against human immunodeficiency virus type 1. Scheme of the 10 steps used for the selection of the best shRNA inhibitors for development of an antiviral RNA interference (RNAi) gene therapy. HIV-1: Human immunodeficiency virus type 1.

Citation: Knoepfel SA, Centlivre M, Liu YP, Boutimah F, Berkhout B. Selection of RNAi-based inhibitors for anti-HIV gene therapy. World J Virol 2012; 1(3): 79-90
URL: https://www.wjgnet.com/2220-3249/full/v1/i3/79.htm
DOI: https://dx.doi.org/10.5501/wjv.v1.i3.79

Knoepfel SA, Centlivre M, Liu YP, Boutimah F, Berkhout B. Selection of RNAi-based inhibitors for anti-HIV gene therapy. World J Virol 2012; 1(3): 79-90 [PMID: 24175213 DOI: 10.5501/wjv.v1.i3.79]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.